BNTX Stock Catalyst Calendar

This week and next: October 18 – October 31, 2026

Last updated: Oct 24, 2026 • 6:11 AM EDT

Why Is BNTX Moving Today?

Get real-time AI-powered explanations for why BNTX stock is moving today.

Find Out

Upcoming BNTX Earnings Dates and Catalysts

No confirmed BNTX stock catalysts are scheduled this week. Investors often watch for upcoming earnings, guidance updates, product launches, partnerships, and demand signals that could move BNTX stock.

Recent Events That Moved BNTX Stock

IASLC 2026 World Conference on Lung Cancer (WCLC 2026)
Mon, Sep 14, 2026 • 9:00 AM EDT

The IASLC 2026 World Conference on Lung Cancer (WCLC 2026) will be taking place. Location:Seoul Republic of Korea -------- Late-breaking oral presentation detailing first global lung cancer data from the Phase 1/2 trial evaluating pumitamig combined with the B7H3-targeting ADC elfetabart drozuntecan in advanced/metastatic NSCLC or SCLC. Location:Seoul Republic of Korea -------- Mini oral presentation of updated overall survival data from stage 1 of the Phase 3 PRESERVE-003 trial evaluating gotistobart versus docetaxel in metastatic squamous NSCLC after progression on prior PD-(L)1 inhibitor therapy. Location:Seoul Republic of Korea -------- Mini oral presentation of preliminary results from a Phase I trial evaluating neoadjuvant BNT116 in combination with cemiplimab carboplatin and paclitaxel in resectable NSCLC.

90% Impact
International Association for the Study of Lung Cancer (IASLC) 2026 World Conference on Lung Cancer (WCLC)
Sat, Sep 12, 2026 • 9:00 AM EDT

The International Association for the Study of Lung Cancer (IASLC) 2026 World Conference on Lung Cancer (WCLC) will be taking place. Location:Seoul Republic of Korea -------- BioNTech will present new clinical data from its lung cancer development program including updates across key strategic assets (pumitamig and gotistobart) and its mRNA-based immunotherapy approaches. Location:Seoul Republic of Korea -------- A late-breaking oral presentation will detail data from the combination trial of pumitamig with the investigational B7H3-targeted antibody-drug conjugate elfetabart drozuntecan (elfe-D) described as the first combination data for any PD-(L)1xVEGF bispecific immunomodulator and an ADC in lung cancer.

90% Impact

Showing the last 8 weeks.

Frequently Asked Questions

When is the next BNTX earnings date?

A confirmed next earnings date for BNTX is not listed in this window. Check the full stock catalyst calendar and earnings calendar for newly added dates.

What events typically move BNTX stock?

Common movers include earnings and guidance, product or service launches, partnerships and M&A headlines, sector news, and macroeconomic releases that change the outlook for BNTX.

Why do investors track BNTX catalyst events?

Catalysts concentrate information flow: they can reset expectations, volatility, and positioning. A dated calendar helps you plan around those windows instead of reacting after the fact.

Does BNTX stock react to retail and macroeconomic data?

Many stocks, including BNTX, can respond to retail sales, consumer confidence, inflation and rates, and peer results that read through to demand and margins—especially when no company-specific headline is scheduled.

What upcoming events could move BNTX stock next?→Why did BNTX stock move up/down today?→
Get started

Never miss a market-moving event

Track company catalysts, earnings, IPOs, macro releases, and more in one calendar.

See upcoming catalysts →